Source comparison
CJC-1295 no DAC & Ipamorelin for Anti-Aging: Peptide Comparison
Researchers frequently compare CJC-1295 no DAC and Ipamorelin to alternative secretagogues and direct GH administration. The table below contrasts mechanisms, half-lives, side effect profiles, and typical research applications. CJC-1295 no DAC GHRH analog. Amp
This comparison does not assign a generated winner or score.
- Researchers frequently compare CJC-1295 no DAC and Ipamorelin to alternative secretagogues and direct GH administration. The table below contrasts mechanisms, half-lives, side effect profiles, and typical research applications.
- CJC-1295 no DAC
- GHRH analog. Amplifies GH pulse amplitude
- 30 min–2 hours
- Lean mass preservation, skin elasticity, metabolic optimization
- Minimal. Transient injection site reaction, rare vasodilation
- Best for physiological GH pulse amplitude without sustained elevation
- Ipamorelin
- Ghrelin receptor agonist. Increases GH pulse frequency
- 2–3 hours
- Body recomposition, sleep quality, tissue repair
- Highly selective. No cortisol or prolactin elevation, no appetite surge
- Cleanest secretagogue profile for anti-aging research
- Sermorelin
- GHRH analog (identical to endogenous GHRH 1-29)
- ~10 minutes
- General GH restoration, very short pulsatile action
- Minimal, but very short half-life requires multiple daily doses
- Effective but less practical than CJC-1295 no DAC due to dosing frequency
- GHRP-6
- Non-selective ghrelin agonist
- ~2 hours
- GH release with appetite stimulation
- Significant hunger increase, cortisol elevation, water retention
- Effective for GH release but side effects limit anti-aging applicability
- Synthetic HGH
- Direct exogenous GH replacement
- ~3 hours (subcutaneous)
- Severe GH deficiency, wasting syndromes
- Insulin resistance, edema, joint pain, receptor desensitization with chronic use
- Not suitable for anti-aging. Bypasses natural pulsatile feedback
- MK-677 (Ibutamoren)
- Oral ghrelin mimetic. Long-acting GH secretagogue
- 24 hours
- Convenient oral dosing for sustained GH elevation
- Appetite increase, possible insulin resistance with long-term use, water retention
- Oral convenience but lacks pulsatile pattern. Less ideal for anti-aging
- The combination of CJC-1295 no DAC and Ipamorelin produces synergistic effects: CJC-1295 amplifies the magnitude of each GH pulse, while Ipamorelin increases the frequency of pulses throughout the day. This dual-action approach mimics youthful secretion patterns more accurately than any single agent and avoids the receptor desensitization that limits long-term efficacy of continuous GH exposure.